
SMN-C3
CAS No. 1449597-34-5
SMN-C3( —— )
Catalog No. M33127 CAS No. 1449597-34-5
SMN-C3 (MV8T2MCK57) is an orally active modulator of SMN2 splicing, and has the potential to treat spinal muscular atrophy (SMA).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 272 | Get Quote |
![]() ![]() |
5MG | 432 | Get Quote |
![]() ![]() |
10MG | 638 | Get Quote |
![]() ![]() |
25MG | 975 | Get Quote |
![]() ![]() |
50MG | 1316 | Get Quote |
![]() ![]() |
100MG | 1728 | Get Quote |
![]() ![]() |
500MG | 3465 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSMN-C3
-
NoteResearch use only, not for human use.
-
Brief DescriptionSMN-C3 (MV8T2MCK57) is an orally active modulator of SMN2 splicing, and has the potential to treat spinal muscular atrophy (SMA).
-
DescriptionSMN-C3 is an orally active SMN2 splicing modulator and has the potential to treat spinal muscular atrophy (SMA).
-
In Vitro——
-
In VivoAt P16, vehicle treated D7 mice are much smaller than heterozygous littermate controls and appear moribund. In contrast, D7 mice treated with the high dose of SMN-C3 show a phenotype similar to that of heterozygous controls. SMN-C3 treatment induces a dose-dependent bodyweight gain in the D7 mice, with some animals showing a body weight that is ~80% that of heterozygous controls. SMN-C3 normalizes the motor behavior of D7 mice, illustrated by the ability of the mice to right themselves as quickly as heterozygous controls and by their level of locomotor activity. Most importantly, whereas vehicle-treated mice die within 3 weeks after birth with a median survival of 18 days, SMN-C3 treatment increases survival in a dose-dependent manner to a median survival time of 28 days in the low-dose (0.3 mg/kg per day) group. In the two higher-dose groups (1 and 3 mg/kg per day), ~90% of animals survive beyond P65 when the study is completed.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1449597-34-5
-
Formula Weight416.52
-
Molecular FormulaC24H28N6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 1.96 mg/mL (4.71 mM; ultrasonic and warming and adjust pH to 5 with HCl and heat to 60°C )
-
SMILESCCN1CCC(CC1)c1cc(C)c2nc(cc(=O)n2c1)-c1cc2c(C)nc(C)cn2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Naryshkin NA, et al. Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science. 2014 Aug 8;345(6197):688-93.?
molnova catalog



related products
-
5-Fluorouridine
5-fluorouridine is also known as FUrd, 5-Fluorouracil 1-beta-D-ribofuranoside, 5-Fur, or 5-Fluoro-uridine. 5-fluorouridine is a solid.
-
Laromustine
Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity.
-
Oosporein
Oosporein is a mycotoxin produced by Trichoderma reesei with antimicrobial, antiviral and insecticidal activities, inhibits P.